IMMUNIZATION & VACCINE PREVENTABLE DISEASES

Similar documents
IMMUNIZATION VACCINE DEVELOPMENT

IMMUNIZATION VACCINES & EMERGENCIES

IMMUNIZATION VACCINE DEVELOPMENT

1) SO1: We would like to suggest that the indicator used to measure vaccine hesitancy be DTP 1 to measles first dose dropout.

CONTENTS. Paragraphs I. BACKGROUND II. PROGRESS REPORT ON THE AFRICAN REGIONAL IMMUNIZATION STRATEGIC PLAN

Malaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA

PROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA

AIDS in Africa. An Update. Basil Reekie

IMMUNIZATION VACCINE DEVELOPMENT

Overview of WHO/UNICEF Immunization Coverage Estimates

What is this document and who is it for?

PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS

FRAMEWORK FOR IMPLEMENTING THE GLOBAL STRATEGY TO ELIMINATE YELLOW FEVER EPIDEMICS (EYE), IN THE AFRICAN REGION. Report of the Secretariat

TFI Proceedings, Recommendations and implications for 2005

MEASLES ELIMINATION BY 2020: A STRATEGY FOR THE AFRICAN REGION. Report of the Secretariat. Executive Summary

40 years of childhood vaccination programmes in Africa. Mind the gap

ASLM Building laboratory capacity in Africa in a sustainable way

POLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12

Global Vaccine Action Plan

IMMUNIZATION VACCINE DEVELOPMENT

Scaling Up Nutrition Action for Africa

Annex 2 A. Regional profile: West Africa

Global reductions in measles mortality and the risk of measles resurgence

Performance of National Measles Case-Based Surveillance Systems in The WHO African Region

ASLM Anti-microbial Resistance in Africa and Global Health Security. 9TH INTEREST WORKSHOP May 2015 Harare

Ouagadougou Declaration

Measles Supplementary Immunization Activities and GAVI Funds as Catalysts for Improving Injection Safety in Africa

CANCER OF THE CERVIX IN THE AFRICAN REGION: CURRENT SITUATION AND WAY FORWARD

GABON. Neglected tropical disease treatment report profile for mass treatment of NTDs

AFRICA. The continent of All challenges

Update from GAVI Aurelia Nguyen

Prioritizing Emergency Polio Eradication Activities

Health situation analysis in the African Region. Basic indicators 2006

Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division

CDER EDITORIAL Through this issue of the

THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL: 10 YEARS OF IMPLEMENTATION IN THE AFRICAN REGION

! Multisectoral Information, Data, Research & Evidence - for Health, Population, Human & Social Development!

Measles Mortality Reduction and Pre- Elimination in the African Region,

TT Procured by UNICEF

Zika Outbreak: a PHEIC & Zika virus preparedness and response ac:vi:es in the African Region. Dr Zabulon Yo, & Dr Anthony Stewart

Children in Africa. Key statistics on child survival, protection and development

Update on PMTCT. African Health Profession Regulatory Collaborative for Nurses and Midwives. Johannesburg, Republic of South Africa, June 18-22, 2012

Ageing and mental health resources for older persons in the African region of the World Health Organization

Health systems and HIV: advocacy. Interagency Coalition on AIDS and Development

Progress has been made with respect to health conditions.

Status Report on WSS MDG Roadmaps and Country Status Overviews WSP Africa

Blood safety in Africa: Progress made during the last decade and major challenges for the Future

The Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control

Analysis of Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form (JRF),

PROGRESS ON HEALTH-RELATED MILLENNIUM DEVELOPMENT GOALS AND THE POST 2015 HEALTH DEVELOPMENT AGENDA. Report of the Secretariat CONTENTS ANNEXES

Financing the HIV response in sub- Saharan Africa from domestic sources: moving beyond a normative approach

GLOBAL VACCINE ACTION PLAN

Fighting Harder and Smarter Against Malaria. Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010

Impact of Pathology Implementation Strategies in Sub Saharan Africa

Excellence and Originality from Necessity: Palliative Care in Africa. Dr Emmanuel Luyirika Executive Director, African Palliative Care Association

Demographic Transitions, Solidarity Networks and Inequality Among African Children: The Case of Child Survival? Vongai Kandiwa

APPENDICES BACKGROUND PAPER ON THE RTS,S/AS01 MALARIA VACCINE SEPTEMBER 2015

Atlas of the African Health Statistics

african vaccination week 2018 (AVW) toolkit #AVW18

COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP)

THE DOUBLE DIVIDEND. Presented at 6 th HIV Paediatric Workshop, Melbourne 19 th July 2014

TURNING POINT FOR AFRICA AN HISTORIC OPPORTUNITY TO END AIDS AS A PUBLIC HEALTH THREAT BY 2030 AND LAUNCH A NEW ERA OF SUSTAINABILITY

Comparative Analyses of Adolescent Nutrition Indicators

Update on Meningococcal A Vaccine Development and Introduction

UNAIDS 2013 AIDS by the numbers

Africa s slow fertility transition

What is the recent experience of programs that distribute contraceptives free of charge versus for a price?

Expert Group Meeting on the Regional Report for the African Gender and Development Index

Towards an Atlas of Human Helminth Infection in sub-saharan Africa: The Use of Geographical Information Systems (GIS)

POLIO ERADICATION IN THE AFRICAN REGION: PROGRESS REPORT. Information document EXECUTIVE SUMMARY

Yellow fever Vaccine investment strategy

Foreword. For further information please contact Dr Nivo Ramanandraibe at and Dr Ahmed E. Ogwell Ouma at

Influenza Surveillance In the WHO African Region

Rotavirus Vaccine: Supply & Demand Update. UNICEF Supply Division

STATUS REPORT ON MALARIA

CHILD SURVIVAL IN SUB-SAHARAN AFRICA TAKING STOCK

The Impact of Population Policies, Non-Governmental Organizations, and HIV/AIDS Policies on Fertility and HIV Prevalence in Sub-Saharan Africa 1

EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT

THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026

AFRICAN GENDER EQUALITY AND WOMEN S EMPOWERMENT SCORECARD

Eligibility List 2018

Global Fund Results Fact Sheet Mid-2011

Okwen PM 1,2, Maweu IW 1,3, Ndimbum CN 1, Evina Danielle 2 Ongolo-Zogo Pierre 2, George Nel 4, Anastase Dzudzie 4, Dike Orji 4, Mayosi Bongani 4

Global Polio Eradication Initiative

MONITORING THE IMPLEMENTATION OF THE HEALTH MILLENNIUM DEVELOPMENT GOALS. Report of the Secretariat. Executive Summary

ANNEX Page. AFR/RC61/11 4 July 2011 ORIGINAL: ENGLISH REGIONAL COMMITTEE FOR AFRICA

Aboubacar Kampo Chief of Health UNICEF Nigeria

Distr.: GENERAL. E/ECA/COE/31/8 AU/CAMEF/EXP/8(VII) 10 February Addis Ababa, Ethiopia March Original: ENGLISH

SECTION II: Tracking Progress 1

CREOLE Study: Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans. CREOLE Study

Incorporating combination polypharmacy into national or provincial CVD control strategies: An African perspective

Funding for AIDS: The World Bank s Role. Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia

Yellow fever laboratory capacity on-site assessments in Africa: preliminary findings

Gender, Poverty, and Health in Sub-Saharan Africa: A Framework for Analysis

Progress Report: Universal Access Target Setting in East and Southern Africa

Downloaded from:

VIEW-hub Report: Global Vaccine Introduction and Implementation

( A JICA-IRRI-PhilRice Initiative) Presented by Noel Magor, Head Unit Impact Acceleration and Training Center, IRRI

HPV Vaccine Lessons Learned & New Ways Forward

Rotavirus vaccines: Issues not fully addressed in efficacy trials

Transcription:

IMMUNIZATION & VACCINE PREVENTABLE DISEASES MONTHLY IMMUNIZATION UPDATE IN THE AFRICAN REGION July-August 2015 (Vol 3, issue N 6 ) Special issue on WHO/UNICEF Estimates of National Immunization Coverage (WUENIC) Coverage of third dose of DTP containing vaccine in AFR, 2013 vs 2014 According to the 2014 WHO & UNICEF Estimates of National Immunization Coverage (WUENIC), the Regional coverage for DTP3 containing vaccine slightly increased from 76% to 77% between 2013 and 2014. Around 25.3 millions children were vaccinated with DTP3 in 2014 compared to 24.3 million in 2013. A total of 18 countries reached 90% coverage for both years The coverage increased in 21 countries including in 3 of the 6 priority countries (Ethiopia, DRC & Nigeria). A decrease in the coverage was observed in 17 countries mainly in the 3 Ebola affected countries (Guinea, Liberia & Sierra Leone) as well as in countries like Angola and Cote d Ivoire, for various reasons including sudden increase in denominator figures and vaccine stock outs respectively. The coverage in Chad, CAR, Equatorial Guinea and South Sudan remained below 50% for both years. Countries having sustained 3 years of DTP3 containing vaccine coverage of at least 90% (2012-2014 ) Global & Regional Vaccine Action plans recommend countries to achieve a national coverage 90% for DTP3 containing vaccine. Analysis of the 2014 WUENIC data show that only 15 out of 47 countries (32%) have been able to meet that target. The surviving infants living in those 15 countries represent only 16% of the total regional target population. The majority of surviving infants in the region still live in countries (32/47) which did not reach the GVAP/RVAP recommended target of 90% coverage at national level, denoting persistent iniquities between countries. Five years through the implementation of GVAP 2011-2020, efforts are very much needed in order to meet and sustain the set goals. Source: WHO/UNICEF estimates August 2014 revision 1

Coverage of first dose of Measles vaccine (MCV1) in AFR, 2013 vs 2014 The WUENIC 2014 show that 14/46 countries in the region have reached 90% coverage for the 1st dose of measles containing vaccine (MCV1) 13 countries have sustained 90% coverage during the past 3 years: Mauritius, Tanzania, Seychelles, Rwanda, Botswana, Eritrea, Gambia, Algeria, Burundi, Zimbabwe, Lesotho, Cape Verde & Sao Tome et Principe. In 16 countries, MCV1 coverage decreased between 2013 & 2014 with significant decrease in 10 countries including the 3 Ebola affected countries (Guinea, Liberia & Sierra Leone) and countries affected by conflicts (South Sudan). Three countries (CAR, Equatorial Guinea and South Sudan) have reported coverage below 50% for both years. Comparison between 2014 DTP3 administrative coverage (JRF) and WUENIC* Chad Comparative analysis of 2014 DTP3 administrative data (JRF) and WUENIC show similar coverage in 29 countries. The WUENIC for Lesotho, was higher than the administrative data highlighting possible underreporting from national administrative system. However, in 17 countries, there was a gap between these 2 sources of data (Administrative data > WUENIC). The highest gap ( 20 points) have been observed in Chad, Niger, South Africa, Equatorial Guinea, Uganda, Benin and Cote d Ivoire. Moderate gap (>10 and <20) was observed in South Sudan, Madagascar, DRC, Liberia, Ethiopia and Mozambique. Minor gap ( 3 and <10) was observed in Guinea, Guinea Bissau, Mali, Nigeria and. These 17 countries are encouraged to strengthen their efforts to improve data quality from the level of data generation. Source: WHO/UNICEF estimates August 2014 revision and JRF 2014 http://www.who.int/immunization/monitoring_surveillance/data/en/ AFRO will continue to provide technical assistance in this process. 2

Countries with highest number of DTP3 unimmunized children, 2013-2014 WUENIC data show that an estimated 7.4 millions children were not reached with DTP3 in 2014 compared to 7.8 million in 2013. Around 75% of these children are located in 10 countries as shown in the beside graph with 50.2% of these children located in 4 countries only (Nigeria, Ethiopia, DRC and Uganda). Five of these countries are among the AFR priority countries, supported in the development and implementation of national immunization coverage improvement plans with specific strategies to reach the unreached children. These are collaborative efforts with other immunization partners. 2014 WUENIC for all antigens per country in AFR 3

Number of countries that have reported vaccines stock outs (in weeks) at national and district level (JRF 2014) Data reported in the 2014 Joint Reporting form (JRF) show that 20/47countries (43%) in the region reported at least one episode of stock out for a duration of at least one week. One country reported stock outs for all Vaccines in the national programme (except PCV which was introduced in September 2014). BCG vaccine has been the most affected antigen for stock out (10 countries), followed by OPV and YF (6 countries). Most of the stock outs at district level were due to unavailability of vaccines at national level. Stock outs at district level have probably contributed to the interruption of vaccination sessions at peripheral level and therefore to the non achievements of the set objectives in many countries. Source: JRF 2014, http://www.who.int/immunization/monitoring_surveillance/data/en/ Funding of immunization programmes by Governments in the AFR in 2014 Analysis of 2014 JRF data indicates that 43 countries in the region confirmed having a budget line for vaccine procurement. Nine countries reported having funded 100% of their vaccine costs. 31 countries are funding <50% of the vaccine cost by their national governments. The situation is completely different for the total funding of routine Immunization activities funded by national Governments. Only 4 countries have funded 100% of heir RI cost and 27 countries funded <50%. This situation highlights the need for strong country ownership of immunization programmes in the African region. Nine countries did not provide this information in their 2014 JRF. Source: JRF 2014, http://www.who.int/immunization/monitoring_surveillance/data/en/ 4

Reported RI Coverage and district performance by country in the AFR, Jan-June 2014-2015 Data reported in this issue cover the period January to June 2014/2015. The completeness was 97% and 91% in 2014 & 2015 respectively. Sierra leone, South Africa & Togo reported a completeness <70%. Algeria & Madagascar a completeness less than 50%. The regional administrative reported DTP3-containing vaccine & Measles vaccine coverage was 83% in 2015 for both antigens compared to 89% and 90% respectively in 2014. A total of 23/47 countries reported a coverage 80% among which 8 countries with a coverage between 80-89%, and 15 others with a coverage >90%. Five countries reported coverage 50% ( Algeria, CAR, Equatorial Guinea, Liberia & Madagascar). An overall trend of decline of t he vaccine coverage is observed in many countries for the period partly due to low completeness in some countries (Madagascar, South Africa). Few countries have shown some increase of their coverage as is the case in Chad, Gabon, Senegal). Source: Country administrative reported data, monthly district data monitoring system, IVD /FRH, WHO/AFRO 5